Mohammed Alnaggar
Xianning, 437000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Synergistic Effect of Fecal Microbiota Transplantation, γδT Cell Immunotherapy, and Pembrolizumab in Refractory Advanced Pancreatic Cancer: A Case Report.
Journal: Journal of gastrointestinal cancer
Published: November 30, 2025
Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management.
Journal: The EPMA journal
Published: December 05, 2024
Adverse physiological effects of smoking cessation on the gastrointestinal tract: A review.
Journal: Medicine
Published: September 25, 2023
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215).
Journal: EClinicalMedicine
Published: August 11, 2023
Fatty infiltration of the pancreas: a systematic concept analysis.
Journal: Frontiers in medicine
Published: May 22, 2023
Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis.
Journal: Frontiers in immunology
Published: August 10, 2021
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer.
Journal: Cellular & molecular immunology
Published: April 15, 2020
Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients.
Journal: Signal transduction and targeted therapy
Published: April 14, 2020
Silver nanoparticles induce cell death of colon cancer cells through impairing cytoskeleton and membrane nanostructure.
Journal: Micron (Oxford, England : 1993)
Published: July 20, 2019
Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: October 03, 2018
Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: January 29, 2018
Last Updated: 09/26/2026